Your browser doesn't support javascript.
loading
Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol.
Sablerolles, Roos S G; Goorhuis, Abraham; GeurtsvanKessel, Corine H; de Vries, Rory D; Huckriede, Anke L W; Koopmans, Marion P G; Lafeber, Melvin; Postma, Douwe F; van Baarle, Debbie; Visser, Leo G; Dalm, Virgil A S H; Kootstra, Neeltje A; Rietdijk, Wim J R; van der Kuy, P Hugo M.
Afiliação
  • Sablerolles RSG; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
  • Goorhuis A; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, Netherlands.
  • GeurtsvanKessel CH; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • de Vries RD; Infection & Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, Netherlands.
  • Huckriede ALW; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
  • Koopmans MPG; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
  • Lafeber M; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • Postma DF; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
  • van Baarle D; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
  • Visser LG; Department of Internal Medicine, University Medical Center Groningen, Groningen, Netherlands.
  • Dalm VASH; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • Kootstra NA; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
  • Rietdijk WJR; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
  • van der Kuy PHM; Department of Internal Medicine, Division of Allergy & Clinical Immunology and Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands.
Front Immunol ; 12: 753319, 2021.
Article em En | MEDLINE | ID: mdl-34691071

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article